Viome Life Sciences announced it had raised $67 million in Series C funding led by Bold Capital Group.
The new funding, which included participation from existing investors Khosla Ventures, West River Group, Glico, Ocgrow Ventures and Physician Partners, brings the company's raise to more than $150 million.
Viome offers gut microbiome tests for consumers and provides nutrition recommendations...
